首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Multimodal visibility of a modified polyzene-fcoated spherical embolic agent for liver embolization: Feasibility study in a porcine model
【24h】

Multimodal visibility of a modified polyzene-fcoated spherical embolic agent for liver embolization: Feasibility study in a porcine model

机译:改性聚苯胺涂层球形栓塞剂用于肝栓塞的多模式可见性:在猪模型中的可行性研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

To evaluate multimodal visibility of modified currently available microspheres on radiography, magnetic resonance (MR) imaging, and computed tomography (CT) in a porcine liver model. Livers of four pigs were embolized with two sizes (100 μm ± 25 and 700 μm ± 50) of modified Embozene Microspheres embedded with different densities of barium sulfate and iodine as radiopaque materials (intensity groups AC, with increasing intensity from A to C for 100 μm and intensities A and C for 700 μm) and iron oxide as magnetic substance for MR imaging visibility. Pigs embolized with currently available Embozene Microspheres served as control groups. Pre- and postinterventional MR imaging (T1- and T2-weighted) and CT were performed. Qualitative and quantitative (ie, determination of signal-to-noise ratio [SNR]) particle visibility was evaluated on radiography, MR imaging, and CT. Modified particles of both sizes were visible on radiography, MR imaging, and CT. Particles in the control group were not visible. For modified particles of both sizes, SNRs measured on MR imaging decreased significantly after embolization (eg, cluster analysis of group A, 100 μm ± 50 particles, T1-weighted, -74.6% ± 3.4; P = .03). For modified particles of both sizes, SNR measured on CT increased significantly after embolization (eg, cluster analysis of group A, 700 μm ± 25 particles, +54.3% ± 13.5; P = .03). Modification of currently available Embozene Microspheres was successful, with multimodal visibility on radiography, MR imaging, and CT in porcine liver. In the future, this might improve procedure accuracy and allow monitoring, control, and improvement of embolotherapy during and after the procedure.
机译:要评估改进的当前可用微球在猪肝模型中的放射线照相,磁共振(MR)成像和计算机断层扫描(CT)的多模态可见性。四只猪的肝脏用两种大小(100μm±25和700μm±50)的改性栓子微球栓塞,其中嵌入了不同密度的硫酸钡和碘作为不透射线的材料(强度组AC,强度从A到C增加100) μm,强度A和C为700μm)和氧化铁作为磁性物质,用于MR成像可见性。用目前可用的栓塞微球栓塞的猪作为对照组。进行介入前和介入后MR成像(T1和T2加权)和CT。定性和定量(即,确定信噪比[SNR])粒子的可见性通过射线照相,MR成像和CT进行评估。在射线照相,MR成像和CT上都可以看到两种尺寸的改性颗粒。对照组中的颗粒不可见。对于两种尺寸的改性颗粒,栓塞后在MR成像上测得的SNR均显着降低(例如,A组的聚类分析,100μm±50颗粒,T1加权,-74.6%±3.4; P = .03)。对于两种尺寸的改性颗粒,栓塞后在CT上测得的SNR均显着增加(例如,A组的聚类分析,700μm±25颗粒,+ 54.3%±13.5; P = .03)。目前可用的Embozene微球的修饰成功,在猪肝X射线照相,MR成像和CT上具有多模式可见性。将来,这可能会提高手术的准确性,并允许在手术期间和之后对栓塞疗法进行监测,控制和改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号